Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Constitutive signaling by the C-terminal fragment of polycystin-1 is mediated by a tethered peptide agonist

Brenda S. Magenheimer, Ericka Nevarez Munoz, Jayalakshmi Ravichandran, View ORCID ProfileRobin L. Maser
doi: https://doi.org/10.1101/2021.08.20.457171
Brenda S. Magenheimer
1The Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA
2Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ericka Nevarez Munoz
1The Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA
3Department of Clinical Laboratory Sciences, University of Kansas Medical Center, Kansas City, KS 66160, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jayalakshmi Ravichandran
3Department of Clinical Laboratory Sciences, University of Kansas Medical Center, Kansas City, KS 66160, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin L. Maser
1The Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA
2Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA
3Department of Clinical Laboratory Sciences, University of Kansas Medical Center, Kansas City, KS 66160, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robin L. Maser
  • For correspondence: [email protected]
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

ABSTRACT

Mutation of the PKD1 gene, encoding polycystin-1 (PC1), is the primary cause of autosomal dominant polycystic kidney disease. PC1 is an 11-transmembrane domain protein that binds and modulates the activity of multiple heterotrimeric G protein families and is thought to function as a non-canonical G protein-coupled receptor (GPCR). PC1 shares a conserved GPCR autoproteolysis inducing [GAIN] domain with the adhesion family of GPCRs, that promotes an auto-catalytic, cis-cleavage at the GPCR proteolysis site (GPS) located proximal to the first transmembrane domain. GPS cleavage divides these receptors into two associated ‘subunits’, the extracellular N-terminal (NTF) and transmembrane C-terminal (CTF) fragments. For the adhesion GPCRs, removal of the NTF leads to activation of G protein signaling as a result of the exposure and subsequent intramolecular binding of the extracellular N-terminal stalk of the CTF, i.e., the tethered cryptic ligand or tethered agonist model. Here, we test the hypothesis that PC1-mediated signaling is regulated by an adhesion GPCR-like, tethered agonist mechanism. Using cell-based reporter assays and mutagenesis of PC1 expression constructs, we show that the CTF form of PC1 requires the stalk for signaling activation and synthetic peptides derived from the PC1 stalk sequence can re-activate signaling by a ‘stalk-less’ CTF. In addition, we demonstrate that ADPKD-associated missense mutations within the PC1 stalk affect signaling and can inhibit GPS cleavage. These results provide a foundation for beginning to understand the molecular mechanism of G protein regulation by PC1 and suggest that a tethered agonist-mediated mechanism can contribute to PKD pathogenesis.

SIGNIFICANCE STATEMENT Mutations of the PKD1 gene, encoding polycystin-1, are the predominant cause of autosomal dominant polycystic kidney disease (ADPKD), a systemic disease that is the 4th leading cause of kidney failure. Polycystin-1 functions as an atypical GPCR capable of binding or activating heterotrimeric G proteins, which is essential for preventing renal cystogenesis. However, little is known regarding its regulation. Polycystin-1 shares structural features with the Adhesion family of GPCRs. In this work, we combined mutagenesis and cellular signaling assays which demonstrated that constitutive activation of signaling by polycystin-1 involves an Adhesion GPCR-like molecular mechanism. This study provides new knowledge regarding the structure-function relationships of polycystin-1 which will stimulate additional areas of investigation and reveal novel avenues of therapeutic intervention for ADPKD.

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • Competing Interests Statement—The authors declare that they have no conflicts of interest with the contents of this article.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 21, 2021.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Constitutive signaling by the C-terminal fragment of polycystin-1 is mediated by a tethered peptide agonist
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Constitutive signaling by the C-terminal fragment of polycystin-1 is mediated by a tethered peptide agonist
Brenda S. Magenheimer, Ericka Nevarez Munoz, Jayalakshmi Ravichandran, Robin L. Maser
bioRxiv 2021.08.20.457171; doi: https://doi.org/10.1101/2021.08.20.457171
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Constitutive signaling by the C-terminal fragment of polycystin-1 is mediated by a tethered peptide agonist
Brenda S. Magenheimer, Ericka Nevarez Munoz, Jayalakshmi Ravichandran, Robin L. Maser
bioRxiv 2021.08.20.457171; doi: https://doi.org/10.1101/2021.08.20.457171

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Biochemistry
Subject Areas
All Articles
  • Animal Behavior and Cognition (6038)
  • Biochemistry (13742)
  • Bioengineering (10475)
  • Bioinformatics (33266)
  • Biophysics (17156)
  • Cancer Biology (14223)
  • Cell Biology (20184)
  • Clinical Trials (138)
  • Developmental Biology (10898)
  • Ecology (16064)
  • Epidemiology (2067)
  • Evolutionary Biology (20384)
  • Genetics (13432)
  • Genomics (18676)
  • Immunology (13801)
  • Microbiology (32252)
  • Molecular Biology (13408)
  • Neuroscience (70229)
  • Paleontology (528)
  • Pathology (2200)
  • Pharmacology and Toxicology (3749)
  • Physiology (5894)
  • Plant Biology (12040)
  • Scientific Communication and Education (1817)
  • Synthetic Biology (3374)
  • Systems Biology (8183)
  • Zoology (1846)